Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by ENDO PHARMS

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
005213 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
007337 New Drug Application Approval New combination (S) Standard review drug
009165 New Drug Application Approval New ester, new salt, or other noncovalent derivative (P) Priority review drug
011707 New Drug Application Approval New formulation (S) Standard review drug (V) Orphan drug
011738 New Drug Application Approval New formulation (S) Standard review drug (V) Orphan drug
013428 New Drug Application Approval New formulation (S) Standard review drug
016020 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
016023 New Drug Application Approval New formulation (P) Priority review drug
017111 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
017118 New Drug Application Approval New indication (P) Priority review drug
017938 New Drug Application Approval New formulation (S) Standard review drug
018101 New Drug Application Approval New formulation (S) Standard review drug
021006 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021463 New Drug Application Approval New formulation (S) Standard review drug
021610 New Drug Application Approval New formulation (S) Standard review drug
021611 New Drug Application Approval New formulation (S) Standard review drug
075923 Abbreviated New Drug Application Tentative Approval
201655 New Drug Application Approval New manufacturer (P) Priority review drug

Back to Companies who have applied for FDA Drug Approval